Neutral amino acid transporter SLC38A2 protects renal medulla from hyperosmolarity-induced ferroptosis

Abstract

Hyperosmolarity of the renal medulla is essential for urine concentration and water homeostasis. However, how renal medullary collecting duct (MCD) cells survive and function under harsh hyperosmotic stress remains unclear. Using RNA-Seq, we identified SLC38A2 as a novel osmoresponsive neutral amino acid transporter in MCD cells. Hyperosmotic stress-induced cell death in MCD cells occurred mainly via ferroptosis, and it was significantly attenuated by SLC38A2 overexpression but worsened by Slc38a2-gene deletion or silencing. Mechanistic studies revealed that the osmoprotective effect of SLC38A2 is dependent on the activation of mTORC1. Moreover, an in vivo study demonstrated that Slc38a2-knockout mice exhibited significantly increased medullary ferroptosis following water restriction. Collectively, these findings reveal that Slc38a2 is an important osmoresponsive gene in the renal medulla and provide novel insights into the critical role of SLC38A2 in protecting MCD cells from hyperosmolarity-induced ferroptosis via the mTORC1 signalling pathway.

Data availability

Sequencing data have been deposited in GEO under accession codes GSE206476.All data analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1-10 and Figures S1-11.Figure 1 - Source Data 1 and Figure 2 - Source Data 1 contain the numerical data used to generate the figures.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Chunxiu Du

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    For correspondence
    chunxiu_du@163.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4152-4663
  2. Hu Xu

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1198-0932
  3. Cong Cao

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Jiahui Cao

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Yufei Zhang

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Cong Zhang

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Rongfang Qiao

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Wenhua Ming

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Yaqing Li

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Huiwen Ren

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6037-8561
  11. Xiaohui Cui

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Zhilin Luan

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    Competing interests
    The authors declare that no competing interests exist.
  13. Youfei Guan

    Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
    For correspondence
    youfeiguan@163.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5231-0209
  14. Xiaoyan Zhang

    Health Science Center, East China Normal University, Shanghai, China
    For correspondence
    xyzhang@hsc.ecnu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Natural Science Foundation of China (82270703)

  • Xiaoyan Zhang

National Natural Science Foundation of China (81970606)

  • Xiaoyan Zhang

National Natural Science Foundation of China (81970595)

  • Youfei Guan

National Key Research and Development Program of China (2020YFC2005000)

  • Youfei Guan

East China Normal University (2022JKXYD03001)

  • Xiaoyan Zhang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The use of animals and the study protocols were reviewed and approved by the Animal Care and Use Review Committee of Dalian Medical University and the study conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (in Guide for the Care and Use of Laboratory Animals, th, Editor. 2011: Washington )

Copyright

© 2023, Du et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,764
    views
  • 323
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chunxiu Du
  2. Hu Xu
  3. Cong Cao
  4. Jiahui Cao
  5. Yufei Zhang
  6. Cong Zhang
  7. Rongfang Qiao
  8. Wenhua Ming
  9. Yaqing Li
  10. Huiwen Ren
  11. Xiaohui Cui
  12. Zhilin Luan
  13. Youfei Guan
  14. Xiaoyan Zhang
(2023)
Neutral amino acid transporter SLC38A2 protects renal medulla from hyperosmolarity-induced ferroptosis
eLife 12:e80647.
https://doi.org/10.7554/eLife.80647

Share this article

https://doi.org/10.7554/eLife.80647

Further reading

    1. Cell Biology
    Satoshi Ninagawa, Masaki Matsuo ... Kazutoshi Mori
    Research Advance

    How the fate (folding versus degradation) of glycoproteins is determined in the endoplasmic reticulum (ER) is an intriguing question. Monoglucosylated glycoproteins are recognized by lectin chaperones to facilitate their folding, whereas glycoproteins exposing well-trimmed mannoses are subjected to glycoprotein ER-associated degradation (gpERAD); we have elucidated how mannoses are sequentially trimmed by EDEM family members (George et al., 2020; 2021 eLife). Although reglucosylation by UGGT was previously reported to have no effect on substrate degradation, here we directly tested this notion using cells with genetically disrupted UGGT1/2. Strikingly, the results showed that UGGT1 delayed the degradation of misfolded substrates and unstable glycoproteins including ATF6α. An experiment with a point mutant of UGGT1 indicated that the glucosylation activity of UGGT1 was required for the inhibition of early glycoprotein degradation. These and overexpression-based competition experiments suggested that the fate of glycoproteins is determined by a tug-of-war between structure formation by UGGT1 and degradation by EDEMs. We further demonstrated the physiological importance of UGGT1, since ATF6α cannot function properly without UGGT1. Thus, our work strongly suggests that UGGT1 is a central factor in ER protein quality control via the regulation of both glycoprotein folding and degradation.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.